Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services
XTalks
DECEMBER 1, 2020
Fortunately, technological advances — such as those pioneered by Menarini Silicon Biosystems — have allowed researchers and healthcare practitioners to decipher these issues, drilling down to single-cell genomic levels to uncover variations that may account for reduced drug efficacy or biochemical resistance.
96 
Let's personalize your content